NCT05232942View on ClinicalTrials.gov

Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

February 15, 2024

Study Completion Date

August 15, 2024

Conditions
MigraineHeadache, Migraine
Interventions
OTHER

Headache calendar completion

The patient will complete an in-paper or electronic calendar, depicting the presence/absence of headache, the median intensity and the need of acute medication.

Trial Locations (1)

47010

RECRUITING

Hospital Clínico Universitario de Valladolid, Valladolid

All Listed Sponsors
lead

Hospital Clínico Universitario de Valladolid

OTHER